Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma.
Hepatitis B Virus X Protein Modulates Chemokine CCL15 Upregulation in Hepatocellular Carcinoma.
复制标题
DOI:
10.2174/1871520621666210302083407
复制
发表时间:
2021-03
影响因子:
2.8
通讯作者:
Ying Li;Chaomin Wang;Ting Zhao;R. Cui;Linfei Hu;Luchen Chang;Xi Wei;Jin Zhang;Yueguo Li
中科院分区:
文献类型:
--
作者:
Ying Li;Chaomin Wang;Ting Zhao;R. Cui;Linfei Hu;Luchen Chang;Xi Wei;Jin Zhang;Yueguo Li
BACKGROUND Hepatitis B virus X protein (HBx) is an indispensable progression factor in hepatocellular carcinoma (HCC). CCL15 could be a peculiar proteomic biomarker of HCC with tumorigenesis and tumor invasion. OBJECTIVE The aim of study was to explore the relationship between HBx and CCL15 expression in HCC. METHODS HBV-positive HCC pathological tissue samples and corresponding adjacent non-tumor liver tissues were clearly collected. The expression of HBx and CCL15 was analyzed by immunohistochemistry, real-time polymerase chain reaction (PCR) and western blot analysis in tissues or in vitro. RESULTS The levels of CCL15 mRNA and protein expression in HCC samples were observably higher than the ones of adjacent non-tumor liver tissues. The CCL15 was significantly associated with the expression of HBx in HBV-positive HCC samples. The up-regulation of HBx induced CCL15 expression in vitro. The high expression score of CCL15 was significant associated with the poor prognosis of HCC patients. CONCLUSIONS The CCL15 expression was observably associated with HBx in HCC patients. The CCL15 may be considered as a indicator in clinical managment of HBV-associated HCC.